NFO period: 27^th June - 11^th July, 2023

Highlights of the NFO:

• Scheme type - An open ended equity scheme investing in healthcare sector


• Investment objective - The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.


• Product suitability - The product is suitable for investors who are seeking capital appreciation over long term equity by investing in stocks of companies in the healthcare sector.


• Minimum Application Amount - First investment is Rs.5000/- and in multiples of Rs.1/- thereafter


• Plan/ Options available - Regular Plan & Direct Plan having Growth and Income Distribution cum Capital Withdrawal (IDCW) (Payout and Re-investment Facility).


• Fund Manager - Mr. Sandeep Tandon, Mr. Ankit Pande, Mr. Sanjeev Sharma and Mr. Vasav Sahgal


• Benchmark - S&P BSE Healthcare TRI